Notification
No new Notification messages
Enviro Infra Engineers IPO is Open!
Apply for the Enviro Infra Engineers IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
anuh pharma ltd. stock

ANUH PHARMA LTD. Share Price

201.4 6.50 (3.33%)
Nov 25 2024 11:46 AM Pharmaceuticals NSE: ANUHPHR

ANUH PHARMA LTD. Share Price Update

As of the latest trading session, ANUH PHARMA LTD. share price is currently at 201.4, which is up by 6.50 from its previous closing. Today, the stock has fluctuated between 197.00 and 204.90. Over the past year, ANUH PHARMA LTD. has achieved a return of 15.35 %. In the last month alone, the return has been 0.64 %. Read More...

ANUH PHARMA LTD. Performance

Day Range

Low197.00 High204.90
200.35

52 Week Range

Low 140.10 High 265.00
200.35

ANUH PHARMA LTD. Share Price

506260

ANUHPHR

img img img img
No Data Available

Open Price

197.00

Prev. Close

194.90

Volume (Shares)

18053.00

Total traded value

36.16

Upper Circuit

233.85

Lower Circuit

155.95

Note: The current prices & values are delayed, Login to your account for live updates.

ANUH PHARMA LTD. Fundamentals


(Standalone)

Market Cap (Cr) 1004.00
PE Ratio (TTM) 16.54
Book Value / Share 60.48
Beta 0.68
ROE 19.49%
EPS (TTM) 11.78
Dividend Yield 1.28%
Net Profit Qtr (Cr) 15.04

ANUH PHARMA LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 165.95
Operating Expense 151.16
Net Profit 15.04
Net Profit Margin (%) 9.06
Earnings Per Share (EPS) 3.00
EBITDA 20.27
Effective Tax Rate (%) 17.31
Particulars JUN 2024 (Values in Cr)
Revenue 137.91
Operating Expense 129.35
Net Profit 9.51
Net Profit Margin (%) 6.89
Earnings Per Share (EPS) 1.90
EBITDA 14.29
Effective Tax Rate (%) 22.49
Particulars MAR 2024 (Values in Cr)
Revenue 163.89
Operating Expense 146.98
Net Profit 15.36
Net Profit Margin (%) 9.37
Earnings Per Share (EPS) 3.06
EBITDA 22.05
Effective Tax Rate (%) 22.10
Particulars DEC 2023 (Values in Cr)
Revenue 172.10
Operating Expense 150.45
Net Profit 19.11
Net Profit Margin (%) 11.10
Earnings Per Share (EPS) 3.81
EBITDA 27.65
Effective Tax Rate (%) 24.45
Particulars SEP 2023 (Values in Cr)
Revenue 149.53
Operating Expense 133.81
Net Profit 13.83
Net Profit Margin (%) 9.24
Earnings Per Share (EPS) 2.76
EBITDA 20.11
Effective Tax Rate (%) 22.60
Particulars MAR 2024 (Values in Cr)
Revenue 647.00
Operating Expense 580.79
Net Profit 60.06
Net Profit Margin (%) 9.28
Earnings Per Share (EPS) 11.98
EBITDA 87.24
Effective Tax Rate (%) 23.30
Particulars MAR 2023 (Values in Cr)
Revenue 527.49
Operating Expense 486.13
Net Profit 36.18
Net Profit Margin (%) 6.85
Earnings Per Share (EPS) 7.22
EBITDA 57.39
Effective Tax Rate (%) 23.78
Particulars MAR 2022 (Values in Cr)
Revenue 486.65
Operating Expense 452.71
Net Profit 30.56
Net Profit Margin (%) 6.27
Earnings Per Share (EPS) 6.10
EBITDA 52.04
Effective Tax Rate (%) 21.88
Particulars MAR 2021 (Values in Cr)
Revenue 431.96
Operating Expense 403.94
Net Profit 28.44
Net Profit Margin (%) 6.58
Earnings Per Share (EPS) 5.67
EBITDA 55.12
Effective Tax Rate (%) 26.25
Particulars MAR 2020 (Values in Cr)
Revenue 306.96
Operating Expense 292.01
Net Profit 14.31
Net Profit Margin (%) 4.66
Earnings Per Share (EPS) 2.85
EBITDA 26.98
Effective Tax Rate (%) 25.31
Particulars MAR 2024 (Values in Cr)
Book Value / Share 58.11
ROE % 19.49
ROCE % 25.44
Total Debt to Total Equity 0.01
EBITDA Margin 11.92
Particulars MAR 2023 (Values in Cr)
Book Value / Share 48.14
ROE % 15.90
ROCE % 20.82
Total Debt to Total Equity 0.01
EBITDA Margin 10.98
Particulars MAR 2022 (Values in Cr)
Book Value / Share 42.66
ROE % 15.11
ROCE % 19.14
Total Debt to Total Equity 0.04
EBITDA Margin 10.82
Particulars MAR 2021 (Values in Cr)
Book Value / Share 38.04
ROE % 12.75
ROCE % 15.72
Total Debt to Total Equity 0.17
EBITDA Margin 11.03
Particulars MAR 2020 (Values in Cr)
Book Value / Share 64.74
ROE % 8.76
ROCE % 10.79
Total Debt to Total Equity 0.15
EBITDA Margin 8.94
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 9.67
Total Assets 445.68
Total Liabilities 445.68
Total Equity 291.21
Share Outstanding 50112000
Price to Book Ratio 4.23
Return on Assets (%) 13.47
Return on Capital (%) 20.48
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.65
Total Assets 404.98
Total Liabilities 404.98
Total Equity 241.22
Share Outstanding 50112000
Price to Book Ratio 1.65
Return on Assets (%) 8.93
Return on Capital (%) 15
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 15.94
Total Assets 347.17
Total Liabilities 347.17
Total Equity 213.77
Share Outstanding 50112000
Price to Book Ratio 2.01
Return on Assets (%) 8.80
Return on Capital (%) 14.09
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 20.09
Total Assets 332.63
Total Liabilities 332.63
Total Equity 190.64
Share Outstanding 50112000
Price to Book Ratio 2.37
Return on Assets (%) 8.54
Return on Capital (%) 13.92
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2.51
Total Assets 326.37
Total Liabilities 326.37
Total Equity 162.20
Share Outstanding 25056000
Price to Book Ratio 1.80
Return on Assets (%) 4.38
Return on Capital (%) 6.92
Particulars MAR 2024 (Values in Cr)
Net Income 78.30
Cash from Operations 31.99
Cash from Investing 0.91
Cash from Financing -8.56
Net change in Cash 5.27
Free Cash Flow 37.01
Particulars MAR 2023 (Values in Cr)
Net Income 47.47
Cash from Operations 67.36
Cash from Investing -43.48
Cash from Financing -12.28
Net change in Cash -1.86
Free Cash Flow 68.91
Particulars MAR 2022 (Values in Cr)
Net Income 39.12
Cash from Operations 38.00
Cash from Investing -7.81
Cash from Financing -19.44
Net change in Cash 1.59
Free Cash Flow 39.61
Particulars MAR 2021 (Values in Cr)
Net Income 38.55
Cash from Operations -9.00
Cash from Investing 52.20
Cash from Financing -33.11
Net change in Cash 0.35
Free Cash Flow -2.85
Particulars MAR 2020 (Values in Cr)
Net Income 19.15
Cash from Operations 54.02
Cash from Investing -76.52
Cash from Financing 22.17
Net change in Cash -5.42
Free Cash Flow 89.65
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.13 31.68 3.00 422.48 37.54 / 77.70
BLISS GVS PHARMA LTD 131.50 16.46 1.37 1384.72 92.25 / 148.95
CIPLA LTD 1486.30 26.00 4.23 120032.91 1165.10 / 1702.00
FERMENTA BIOTECH LIMITED 326.15 113.25 3.30 959.89 145.00 / 354.60
GLAXOSMITHKLINE PHARMA LT 2415.20 51.03 24.46 40914.95 1615.65 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.13 47.94 9.37 422.48 37.54 / 77.70
AMRUTAJAN HEALTH LTD 697.90 42.45 6.77 2017.67 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6336.90 123.07 23.31 15842.25 4050.15 / 8139.85
BLISS GVS PHARMA LTD 131.50 17.12 1.35 1384.72 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 192.50
  • 26 Days 195.80
  • 10 Days 194.40
  • 50 Days 200.20
  • 12 Days 194.10
  • 100 Days 206.70
  • 20 Days 193.90
  • 200 Days 182.20
193.07
PIVOT
First Resistance 197.83
Second Resistance 200.77
Third Resistance 205.53
First Support 190.13
Second Support 185.37
Third Support 182.43
RSI 52.61
MACD -1.69
Commodity Channel Index (CCI) -26.32
ADX 40.53
Williams % R -67.68

Over 1 Month

down

0.64

Over 3 Months

down

-7.23

Over 6 Months

down

-17.02

Over 1 Year

down

15.35

Over 3 Years

down

23.28

Over 5 Years

down

24.36

ANUH PHARMA LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ANUH PHARMA LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
30.06
Promoter Holdings
69.91
FII
0.02
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%

ANUH PHARMA LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-08-11 2.0 Final 2023-08-11 Equity shares 2022-08-03 1.75 Final 2022-08-05 Equity shares 2021-08-17 1.5 Final 2021-08-19 Equity shares 2020-03-05 2.75 Interim 2020-03-06 Equity shares 2019-08-14 2.75 Final 2019-08-19 Equity shares 2018-07-27 2.75 Final 2018-07-31 Equity shares 2017-09-15 2.5 Final 2017-09-19 Equity shares 2016-09-15 0.5 Final 2016-09-19 Equity shares 2016-03-22 2.0 Interim 2016-03-23 Equity shares 2015-07-01 5.0 Final 2015-07-03 Equity shares 2014-09-04 6.5 Final 2014-09-08 Equity shares 2014-09-04 2.0 Interim 2014-09-08 Equity shares 2014-03-07 1.25 Special 2014-03-10 Equity shares 2013-07-25 6.0 Final 2013-07-29 Equity shares 2012-08-16 5.5 Final 2012-08-20 Equity shares 2011-09-21 5.0 Final 2011-09-23 Equity shares 2010-02-22 10.0 Interim 2010-02-23 Equity shares 2009-09-09 9.0 Final 2009-09-11 Equity shares 2009-09-09 2.5 Special 2009-09-11 Equity shares 2008-09-04 8.0 Final 2008-09-08 Equity shares 2007-03-22 7.0 Final 2007-03-23 Equity shares 2005-09-21 0.0 Final 2005-09-23 Equity shares
Ex-Date Ex-Bonus Ratio
2020-09-21 2020-09-18 1:1 2015-08-06 2015-08-05 2:1 2010-10-29 2010-10-28 2:1 2006-08-07 2006-07-31 1:1 1999-09-16 1999-08-23 1:1 1995-03-28 1995-02-24 3:1
Ex-Date Old FV NEW FV Record Date
2006-07-31 10.0 5.0 2006-08-07

Learn More About Stocks

About ANUH PHARMA LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ANUH PHARMA LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Anuh Pharma Ltd?

Answer Field

The share price of Anuh Pharma Ltd for NSE is ₹ 0.00 and for BSE is ₹ 200.35.

What is the Market Cap of Anuh Pharma Ltd?

Answer Field

The market cap of Anuh Pharma Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 10,04.00 Cr. as of now.

What is the 52 Week High and Low of Anuh Pharma Ltd?

Answer Field

The 52 Week High and Low of Anuh Pharma Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 265.00 and ₹ 140.10.

How to Buy Anuh Pharma Ltd share?

Answer Field

You can trade in Anuh Pharma Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Anuh Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 15.35%.

What is the Current Share Price of Anuh Pharma Ltd?

Answer Field

Anuh Pharma Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 200.35 as on Nov 25 2024 11:46 AM.

What is the Market Cap of Anuh Pharma Ltd Share?

Answer Field

The market cap of Anuh Pharma Ltd for NSE ₹ 0.0 & for BSE ₹ 10,04.00 as on Nov 25 2024 11:46 AM.

What is the P/E Ratio of Anuh Pharma Ltd Share?

Answer Field

As on Nov 25 2024 11:46 AM the price-to-earnings (PE) ratio for Anuh Pharma Ltd share is 16.54.

What is the PB ratio of Anuh Pharma Ltd Share?

Answer Field

As on Nov 25 2024 11:46 AM, the price-to-book (PB) ratio for Anuh Pharma Ltd share is 60.48.

How to Buy Anuh Pharma Ltd Share?

Answer Field

You can trade in Anuh Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Anuh Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Anuh Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Anuh Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader